porcin
epidem
diarrhea
viru
pedv
pose
great
threat
global
swine
industri
unreli
protect
induc
current
avail
vaccin
remain
major
challeng
previous
gener
genogroup
pedv
taiwan
pintung
pedvpt
strain
determin
promis
host
immun
respons
virul
strain
studi
attenu
determin
establish
recombin
vector
vaccin
platform
antigen
modif
fulllength
cdna
clone
establish
compar
parent
viru
viru
show
effici
replic
kinet
delay
declin
viral
load
similar
much
uniform
plaqu
size
vero
cell
piglet
model
fecal
viral
shed
observ
piglet
wherea
inocul
show
neither
detect
fecal
viral
shed
pedvassoci
clinic
sign
moreov
inocul
elicit
compar
level
antipedv
specif
plasma
igg
fecalsalivari
iga
neutral
antibodi
titer
similar
less
effect
immunoprotect
virul
challeng
compar
parent
present
studi
infecti
cdna
clone
attenu
pedv
strain
success
gener
first
time
vitro
vivo
data
indic
attenu
remain
immunogen
compar
parent
viral
stock
success
develop
cdna
clone
could
allow
manipul
viral
genom
studi
viral
pathogenesi
facilit
rapid
develop
effect
vaccin
porcin
epidem
diarrhea
viru
pedv
envelop
positivesens
singlestrand
rna
viru
belong
order
nidoviral
famili
coronavirida
genu
alphacoronaviru
genom
pedv
kilobas
pair
length
compris
seven
open
read
frame
orf
includ
b
gene
constitut
two
third
genom
encod
replic
complex
spike
gene
govern
viral
entri
envelop
e
membran
nucleocapsid
n
gene
respons
virion
assembl
accessori
gene
undetermin
function
porcin
epidem
diarrhea
viru
caus
agent
porcin
epidem
diarrhea
ped
histor
highli
contagi
enter
swine
diseas
character
diarrhea
dehydr
growth
retard
pig
age
late
new
highli
virul
pedv
strain
aros
china
spread
rapidli
worldwid
late
result
nearli
mortal
affect
nurs
piglet
date
still
indel
endem
consider
econom
loss
global
swine
market
besid
protect
confer
current
avail
vaccin
unfortun
unsatisfactori
base
nucleotid
ident
gene
pedv
categor
four
genogroup
gs
name
among
pedv
strain
predomin
field
asia
north
america
show
higher
pathogen
appear
elicit
broader
protect
across
differ
genogroup
although
increas
virul
new
pedv
strain
ascrib
sever
mutat
gene
viral
escap
antibodi
neutral
induc
tradit
vaccin
detail
mechan
remain
elus
previous
gener
attenu
taiwan
pedv
strain
pedv
pintung
passag
viru
serial
passag
parent
pedvpt
strain
vero
cell
despit
high
potenti
futur
vaccin
candid
pedv
indic
reduc
pathogen
robust
host
immun
respons
piglet
model
difficulti
pedv
isol
subsequ
lengthi
passag
process
render
unabl
promptli
respond
vast
outbreak
late
year
zhou
et
al
report
new
disastr
swine
diseas
outbreak
china
caus
coronaviru
bat
origin
highlight
potenti
burden
interspeci
jump
coronaviru
press
need
readili
applic
vaccin
platform
new
emerg
revers
genet
system
wide
use
studi
viral
pathogenesi
novel
vaccin
design
present
report
pedv
infecti
cdna
clone
exclus
construct
base
sequenc
repres
wildtyp
pedv
isol
consequ
highli
pathogen
fatal
suckl
piglet
compar
parent
virus
regard
vaccin
use
genet
edit
necessari
attenu
recombin
virus
altern
complementari
approach
exploit
attenu
phenotyp
address
safeti
concern
describ
present
studi
fulllength
cdna
clone
attenu
gener
addit
pathogen
immunogen
protect
virul
challeng
evalu
piglet
model
data
suggest
viru
attenu
abl
elicit
similar
immunogen
immunoprotect
autolog
virul
challeng
compar
parent
viru
cdna
clone
expect
allow
manipul
viral
genom
studi
viral
pathogenesi
hand
serv
vaccin
platform
exampl
directli
replac
gene
emerg
swine
coronavirus
vero
cell
atcc
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
grand
island
ny
usa
supplement
fetal
bovin
protein
fb
ngml
amphotericin
b
uml
penicillin
streptomycin
viral
stock
postinocul
medium
pi
medium
contain
dmem
supplement
tryptos
phosphat
broth
tbp
yeast
extract
trypsin
prepar
previou
studi
use
gener
infecti
cdna
clone
control
vivo
vitro
studi
wherea
virul
viru
use
anim
challeng
strategi
use
engin
fulllength
cdna
clone
name
modifi
accord
previous
publish
method
briefli
complet
genom
genbank
access
divid
six
fragment
pcr
amplif
use
primer
pair
tabl
incorpor
specif
typeii
restrict
enzym
site
seamless
ligat
fragment
contain
promot
sequenc
end
allow
vitro
transcript
sequenc
design
follow
articl
publish
previous
sequenc
ad
end
fragment
f
simul
polyadenyl
natur
occur
bsai
site
fragment
e
remov
introduc
silent
mutat
sitedirect
mutagenesi
accord
previous
describ
protocol
addit
synonym
mutat
gener
near
junction
fragment
e
f
creat
novel
bsmbi
recognit
site
pcr
amplicon
fragment
subclon
plasmid
vector
thermo
fisher
scientif
waltham
usa
subclon
digest
correspond
typeii
restrict
enzym
indic
figur
gelpurifi
use
qiaquick
gel
extract
kit
qiagen
hilden
germani
assembl
fulllength
cdna
conduct
employ
ligas
neb
ipswich
usa
overnight
c
ligat
fulllength
cdna
phenolchloroform
extract
vitro
transcrib
fulllength
rna
transcript
use
mmessag
mmachin
transcript
kit
ambion
austin
ca
usa
follow
manufactur
instruct
cap
analog
gtp
ratio
adjust
increas
yield
fulllength
transcript
facilit
viral
recoveri
nucleocapsid
n
transcript
also
gener
amplicon
flank
entir
n
gene
addit
promot
sequenc
polya
tail
end
respect
n
transcript
precipit
use
lithium
chlorid
ambion
austin
ca
usa
purifi
ethanol
reaction
mixtur
fulllength
transcript
n
transcript
mix
thoroughli
electropor
vero
cell
suspens
cellsml
rnasefre
phosphat
buffer
salin
pb
use
gene
pulser
electropor
system
biorad
hercul
ca
usa
four
puls
v
rest
puls
electropor
cell
initi
incub
room
temperatur
min
resuspend
dmem
supplement
fb
flask
overnight
c
allow
recoveri
next
day
cell
wash
twice
dulbecco
phosphatebuff
salin
dpb
maintain
pi
medium
addit
day
cytopath
effect
cpe
character
cell
fusion
syncyti
cell
format
cell
detach
observ
whole
flask
subject
one
freezeandthaw
cycl
rescu
viru
passag
gener
viral
stock
use
viral
stock
titrat
vero
cell
plate
determin
viral
titer
detect
pedv
antigen
immunocytochemistri
icc
perform
describ
previous
briefli
vero
cell
infect
show
typic
cpe
fix
icecold
aceton
airdri
incub
inhous
antipedv
n
antibodi
room
temperatur
rt
h
wash
three
time
pb
polyclon
antirabbitmous
immunoglobulin
envisiondab
system
dako
carpinteria
ca
usa
appli
h
rt
follow
three
wash
pb
cell
incub
diaminobenzidin
dab
chromogen
peroxidas
dab
substrat
kit
dako
carpinteria
ca
usa
accord
manufactur
instruct
posit
signal
visual
invert
light
microscop
nikon
tokyo
japan
sequenc
analysi
conduct
describ
previous
primer
pair
list
tabl
target
genom
nucleotid
use
identifi
presenc
marker
mutat
viral
stock
growth
characterist
vero
cell
evalu
compar
examin
growth
kinet
plaqu
morpholog
confluent
monolay
vero
cell
prepar
plate
infect
viru
multipl
infect
moi
h
c
triplic
determin
growth
kinet
cell
wash
twice
dpb
maintain
pi
medium
supernat
indic
time
point
h
postinocul
hpi
collect
subject
titrat
vero
cell
seed
plate
plaqu
assay
perform
character
plaqu
morpholog
adsorpt
pedv
moi
vero
cell
wash
twice
dpb
overlaid
pi
medium
contain
agaros
invitrogen
carlsbad
usa
prewarm
c
upon
solidif
overlay
plate
incub
day
c
allow
pedvinfect
vero
cell
produc
distinct
plaqu
cell
fix
neutral
formalin
h
rt
semisolid
overlay
remov
manual
cell
stain
crystal
violet
ethanol
distil
water
min
viral
plaqu
inspect
wash
crystal
violet
rins
plate
water
airdri
rt
diamet
repres
plaqu
viru
measur
compar
fifteen
larg
white
duroc
crossbr
piglet
pedvseroneg
pedvshed
neg
select
convent
pig
farm
histori
pedv
strain
infect
piglet
randomli
assign
three
group
includ
group
n
group
n
mock
group
n
acclim
one
week
prior
inocul
week
age
piglet
group
oral
inocul
ml
tcid
ml
tcid
ml
viru
pi
medium
respect
evalu
protect
efficaci
induc
piglet
week
age
group
oral
challeng
ml
tcid
ml
anim
experiment
procedur
review
approv
institut
anim
care
use
committe
iacuc
nation
taiwan
univers
taiwan
republ
china
approv
fecal
consist
monitor
daili
score
visual
normal
loos
semifluid
wateri
describ
previous
bodi
weight
piglet
measur
weekli
quantit
viral
rna
stool
fecal
sampl
collect
rectal
swab
resuspend
dpb
pulsevortex
precipit
centrifug
rpm
min
rna
extract
automat
stool
suspens
qiacub
use
cador
pathogen
qiacub
ht
kit
qiagen
hilden
germani
accord
manufactur
instruct
cdna
reversetranscrib
use
quantinova
revers
transcript
kit
qiagen
hilden
germani
follow
manufactur
protocol
use
quantit
realtim
pcr
analysi
qpcr
qpcr
conduct
use
previous
publish
primerprob
set
quantinova
probe
pcr
kit
qiagen
hilden
germani
thermal
cycler
biorad
hercul
ca
usa
thermal
profil
compris
initi
denatur
c
min
follow
cycl
c
follow
c
detect
limit
assay
determin
gener
standard
curv
serial
dilut
known
amount
vitro
transcrib
rna
follow
revers
transcript
qpcr
quantif
describ
detect
limit
calcul
rna
copi
per
ml
detect
pedv
specif
plasma
igg
fecal
salivari
iga
inhous
pedv
protein
base
indirect
enzymelink
immunosorb
assay
elisa
conduct
describ
previou
studi
brief
flatbottom
microtit
plate
nunc
roskild
denmark
coat
purifi
recombin
pedvpt
protein
ngwell
incub
overnight
c
plate
wash
six
time
pbst
pb
contain
tween
block
block
buffer
bovin
serum
albumin
pb
rt
h
detect
plasma
igg
dilut
plasma
sampl
block
buffer
ad
follow
six
wash
incub
rt
h
fecal
salivari
iga
elut
fecal
suspens
saliva
dilut
block
buffer
ad
follow
six
wash
kept
overnight
c
incub
sampl
discard
plate
wash
six
time
detect
plasma
igg
fecal
salivari
iga
either
horseradish
peroxidas
hrp
conjug
goat
antipig
igg
kirkegaard
perri
laboratori
milford
usa
dilut
goatantipig
iga
abcam
cambridg
uk
dilut
ad
respect
incub
rt
h
follow
wash
step
tetramethylbenzidin
tmb
substrat
solut
kirkegaard
perri
laboratori
ad
allow
color
develop
rt
min
reaction
termin
ad
tmb
stop
solut
kirkegaard
perri
laboratori
well
optic
densiti
od
nm
measur
elisa
reader
molecular
devic
sunnyval
ca
usa
antibodi
titer
express
sampletoposit
control
ratio
sp
ratio
valu
plasma
sampl
piglet
heat
c
min
inactiv
complement
prior
use
well
mixtur
contain
viru
viral
particl
dilut
plasma
sampl
pi
medium
incub
c
h
appli
vero
cell
well
incub
virusplasma
mixtur
h
vero
cell
wash
twice
maintain
pi
medium
h
cytopath
effect
detect
use
invert
light
microscopi
nikon
tokyo
japan
neutral
titer
defin
highest
dilut
without
cpe
result
bodi
weight
antibodi
titer
viral
titer
growth
kinet
time
point
fecal
viral
shed
analyz
statist
graphpad
prism
graphpad
softwar
san
diego
ca
usa
twoway
anova
time
p
valu
less
consid
statist
signific
gener
fulllength
cdna
clone
complet
genom
sequenc
split
six
fragment
design
primer
pair
fuse
specif
typeii
restrict
enzym
restrict
enzym
digest
dna
ligat
transcript
contain
fulllength
sequenc
success
prepar
typic
pedvassoci
cytopath
effect
vero
cell
character
multinucl
giant
syncytia
observ
one
day
postelectropor
figur
presenc
confirm
detect
pedv
n
protein
immunocytochemistri
figur
sequenc
analys
identif
introduc
substitut
figur
addit
day
recombin
viral
supernat
harvest
cpe
reach
confluent
monolay
viral
stock
titer
tcid
ml
prepar
addit
passag
viral
supernat
vero
cell
character
recombin
plaqu
morpholog
growth
kinet
recombin
vero
cell
compar
parent
viru
interestingli
asid
constantli
short
diamet
plaqu
size
appear
uniform
figur
replic
capac
multistep
growth
kinet
virus
vero
cell
examin
moi
replic
rapidli
titer
tcid
ml
hpi
reach
peak
viral
titer
tcid
ml
hpi
show
declin
viral
titer
tcid
ml
hpi
show
steadi
increas
viral
progeni
significantli
decreas
viral
titer
tcid
ml
hpi
compar
viral
titer
tcid
ml
hpi
significantli
high
viral
titer
tcid
ml
hpi
figur
moi
similar
observ
moi
replic
slower
begin
reach
similar
peak
viral
titer
compar
show
rel
slower
reduct
viral
titer
reach
peak
titer
see
figur
evalu
pathogen
viru
crossbr
piglet
oral
inocul
ml
tcid
ml
viru
viru
pi
medium
clinic
impact
viral
inocul
piglet
evalu
daili
clinic
fecal
score
fecal
viral
shed
weekli
bodi
weight
chang
studi
signific
differ
bodi
weight
reveal
among
differ
group
indic
time
point
figur
one
piglet
group
show
intermitt
loos
diarrhea
score
viral
shed
day
postinocul
dpi
peak
viral
titer
log
rna
copiesml
dpi
figur
evid
pedvassoci
clinic
sign
fecal
viral
shed
demonstr
mock
group
oral
inocul
piglet
virus
system
pedvspecif
igg
blood
mucos
specif
iga
fece
saliva
measur
indic
time
point
compar
mock
group
elev
mean
sp
ratio
blood
pedvspecif
igg
detect
dpi
sustain
dpi
piglet
group
figur
moreov
subtl
increas
mean
sp
ratio
fecal
salivari
pedvspecif
iga
also
observ
group
compar
mock
group
dpi
figur
oral
inocul
virul
viru
daili
fecal
viral
shed
fecal
consist
group
evalu
similar
previou
data
piglet
mock
group
show
differ
sever
clinic
sign
diarrhea
day
postchalleng
dpc
figur
mean
valu
pedv
rna
copi
fece
mock
group
becam
detect
dpc
shot
peak
titer
log
rna
copiesml
dpc
declin
constantli
low
viral
load
approxim
log
rna
copiesml
dpc
group
two
piglet
show
loos
diarrhea
score
one
day
dpc
respect
onset
fecal
viral
shed
group
challeng
delay
dpc
compar
two
group
highest
viral
titer
group
also
appear
dpc
calcul
log
rna
copiesml
group
pig
remain
clinic
normal
without
observ
diarrhea
compar
mock
group
three
five
pig
group
establish
fecal
viral
shed
experi
delay
onset
steadili
fluctuat
low
viral
shed
rang
highest
titer
log
rna
copiesml
undetect
level
figur
mock
group
mean
valu
sp
ratio
system
pedvspecif
igg
titer
blood
piglet
remain
unchang
prior
challeng
mean
sp
valu
rose
dpc
figur
hand
mean
valu
system
pedvspecif
igg
blood
group
increas
sharpli
dpc
respect
significantli
higher
mock
group
figur
mucos
immun
similar
trend
notic
system
pedvspecif
igg
blood
signific
increas
mean
sp
valu
fecal
salivari
antipedv
specif
iga
note
group
challeng
figur
among
sp
valu
salivari
antipedv
specif
iga
group
respect
significantli
higher
mock
group
dpc
figur
vn
antibodi
titer
piglet
group
depict
figur
similar
trend
observ
system
plasma
igg
titer
group
show
compar
vn
antibodi
titer
group
studi
mean
vn
antibodi
titer
group
increas
mildli
dpc
spectacularli
dpc
higher
mock
group
studi
figur
data
express
mean
standard
deviat
statist
signific
differ
group
examin
use
twoway
anova
time
present
studi
describ
first
develop
infecti
cdna
clone
evalu
vitro
vivo
characterist
compar
parent
viru
replic
slowli
begin
reach
similar
peak
viral
titer
similar
uniform
plaqu
size
suggest
composit
viral
quasispeci
less
complex
origin
stock
moreov
neither
fecal
pedv
rna
shed
pedvassoci
clinic
ill
detect
convent
piglet
inocul
viru
indic
attenu
phenotyp
vivo
importantli
piglet
group
show
compar
level
antipedv
specif
plasma
igg
fecalsalivari
iga
plasma
neutral
antibodi
titer
weaken
modest
immunoprotect
virul
challeng
compar
parent
piglet
taken
togeth
result
suggest
immunogen
piglet
could
potenti
safe
viral
vector
candid
vaccin
develop
inocul
demonstr
complet
protect
piglet
develop
diarrhea
challeng
virul
group
show
earlier
onset
longer
durat
fecal
pedv
rna
shed
higher
peak
valu
parent
group
data
suggest
confer
rel
weaken
protect
parent
consid
major
variat
virus
heterogen
viral
popul
note
plaqu
assay
wherein
viru
produc
uniform
plaqu
parent
viru
vero
cell
specul
decreas
quasispeci
divers
may
partli
contribut
attenu
vivo
investig
specul
conduct
next
gener
sequenc
ng
determin
quasispeci
divers
virus
explor
recov
variant
previou
publish
sequenc
gener
sanger
sequenc
see
tabl
result
clearli
demonstr
carri
greater
sequenc
divers
includ
singl
nucleotid
variant
snv
result
amino
acid
substitut
interest
seven
snv
found
spike
gene
virul
exclud
artifici
introduc
marker
mutat
deriv
snv
upon
initi
construct
subclon
snv
uncov
inde
gener
virus
highfidel
replic
propos
ration
strategi
develop
genet
stabl
safe
attenu
vaccin
howev
attenu
virus
vivo
fit
antigen
alreadi
abat
serial
cell
cultur
passag
basi
quasispeci
theori
cooper
interplay
differ
variant
determin
viral
characterist
includ
virul
possibl
consensu
sequenc
use
construct
longer
sustain
origin
affin
virushost
interact
viral
replic
enterocyt
therefor
impair
viral
entri
andor
limit
viral
infect
furthermor
limit
divers
gene
viral
stock
might
also
diminish
potenc
protect
broad
induc
antibodi
respons
explain
compar
level
system
mucos
antibodi
respons
weaken
protect
group
specul
could
test
compar
tissu
tropism
quantiti
pedv
antigen
enterocyt
use
piglet
model
explan
attenu
might
attribut
possibl
addit
five
nucleotid
ggaga
extrem
utr
base
primer
design
see
tabl
consid
locat
addit
nucleotid
sequenc
neither
alter
secondari
structur
stemloop
serv
cisact
element
requir
drive
subgenom
rna
synthesi
chang
consensu
transcript
regulatori
sequenc
xua
ag
assum
effect
addit
nucleotid
rescu
viru
replic
might
minim
nonetheless
studi
requir
determin
potenti
effect
five
addit
nucleotid
replic
present
studi
profil
fecal
pedv
rna
shed
pattern
antibodi
respons
inocul
appear
milder
observ
previou
find
despit
fact
viral
stock
use
convent
piglet
use
studi
purchas
pig
farm
hous
anim
facil
describ
previous
seem
convent
piglet
use
current
studi
resist
infect
sever
host
factor
genet
variat
type
feed
gut
microflora
immun
statu
among
differ
litter
time
inocul
may
play
import
role
vari
sever
clinic
outcom
immun
respons
ideal
discrep
previou
experi
might
minim
expand
size
group
particularli
chose
convent
piglet
target
anim
nevertheless
due
difficulti
collect
larg
number
pedvneg
piglet
taiwan
ped
becom
endem
decid
use
five
piglet
per
treatment
reach
statist
effect
practic
although
use
convent
pig
often
magnifi
variabl
result
higher
variat
experiment
result
mimic
pathogen
immunoprotect
pedv
field
condit
convent
pig
model
still
prefer
preclin
trial
model
sinc
sudden
appear
sever
acut
respiratori
syndromecoronaviru
sarscov
earli
centuri
emerg
reemerg
coronavirus
continu
threaten
global
public
anim
health
caus
sever
ill
high
potenti
zoonosi
caus
great
econom
loss
indic
desper
need
effect
readili
respons
vaccin
platform
larg
genom
size
coronavirus
warrant
great
toler
foreign
gene
subsequ
express
heterolog
antigen
addit
insert
antigen
replac
accessori
gene
creat
novel
express
cassett
also
attract
approach
design
multival
vaccin
concept
could
potenti
safe
vaccin
backbon
facilit
prompt
gener
chimer
vaccin
induct
mucos
immun
instanc
viral
antigen
manipul
replac
gene
pedv
emerg
swine
coronavirus
although
potenti
loss
attenu
due
substitut
requir
clarif
howev
noteworthi
inher
genet
instabl
coronavirus
due
high
recombin
mutat
frequenc
also
matter
concern
rais
possibl
virul
revers
acquisit
new
tropism
besid
intrins
characterist
gene
interest
target
locu
within
coronaviru
genom
may
also
affect
express
level
stabil
recombin
virus
accordingli
character
virul
variat
genet
stabil
differ
genet
modif
need
conduct
articl
describ
first
success
construct
attenu
pedv
infecti
cdna
clone
viru
demonstr
mainten
fit
vitro
along
attenu
vivo
also
propos
initi
low
quasispeci
divers
addit
nucleotid
end
may
contribut
attenu
phenotyp
potenti
less
effect
immunoprotect
virul
strain
challeng
base
result
antibodi
respons
primeboost
strategi
optim
antigen
essenti
induc
suffici
protect
immun
recipi
togeth
fulllength
cdna
clone
gener
herein
expect
provid
access
studi
attenu
determin
establish
recombin
vector
vaccin
platform
develop
multival
vaccin
pedv
porcin
pathogen
